Antoine Awad - Net Worth and Insider Trading
Antoine Awad Net Worth
The estimated net worth of Antoine Awad is at least $51,137 dollars as of 2023-03-30. Antoine Awad is the COO of Synlogic Inc and owns about 81,170 shares of Synlogic Inc (SYBX) stock worth over $51,137. Details can be seen in Antoine Awad's Latest Holdings Summary section.
Transaction Summary of Antoine Awad
Antoine Awad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Antoine Awad owns 1 companies in total, including Synlogic Inc (SYBX) .
Click here to see the complete history of Antoine Awad’s form 4 insider trades.
Insider Ownership Summary of Antoine Awad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYBX | Synlogic Inc | 2020-07-30 | Chief Operating Officer |
Antoine Awad Latest Holdings Summary
Antoine Awad currently owns a total of 1 stock. Antoine Awad owns 81,170 shares of Synlogic Inc (SYBX) as of April 4, 2022, with a value of $51,137.
Latest Holdings of Antoine Awad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYBX | Synlogic Inc | 2022-04-04 | 81,170 | 0.63 | 51,137 |
Holding Weightings of Antoine Awad
Antoine Awad Form 4 Trading Tracker
According to the SEC Form 4 filings, Antoine Awad has made a total of 1 transactions in Synlogic Inc (SYBX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Synlogic Inc is the sale of 2,650 shares on April 4, 2022, which brought Antoine Awad around $6,493.
Insider Trading History of Antoine Awad
- 1
Antoine Awad Trading Performance
Antoine Awad Ownership Network
Ownership Network List of Antoine Awad
Ownership Network Relation of Antoine Awad
Antoine Awad Owned Company Details
What does Synlogic Inc do?
Synlogic Inc is a biopharmaceutical company focused on the discovery and development of Synthetic Biotic medicines which are designed to metabolize a toxic substance, compensate for missing or damaged metabolic pathways, or deliver combinations of therapeutic factors. Synthetic Biotic medicines are generated from the company's proprietary drug discovery and development platform, using Synthetic Biology and leveraging a reproducible, modular approach to develop beneficial microbes that perform or deliver critical therapeutic functions. Its key product candidate is SYNB1618, an oral therapy intended for the treatment of PKU, a rare metabolic disease in which an amino acid known as phenylalanine accumulates in the body as a result of genetic defects.
Who are the key executives at Synlogic Inc?
Antoine Awad is the Chief Operating Officer of Synlogic Inc. Other key executives at Synlogic Inc include Chief Financial Officer Michael Vangsted Jensen , See Remarks Gregg Beloff , and Chief Medical Officer Richard J. Riese .
Synlogic Inc (SYBX) Insider Trades Summary
Over the past 18 months, Antoine Awad made 1 insider transaction in Synlogic Inc (SYBX) with a net sale of 2,650. Other recent insider transactions involving Synlogic Inc (SYBX) include a net purchase of 9,500 shares made by Michael Vangsted Jensen , a net sale of 8,894 shares made by Aoife Brennan ,
In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,544 shares of Synlogic Inc (SYBX) were sold and 9,500 shares were bought by its insiders, resulting in a net sale of 2,044 shares.
Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synlogic Inc Insider Transactions
Antoine Awad Mailing Address
Above is the net worth, insider trading, and ownership report for Antoine Awad. You might contact Antoine Awad via mailing address: C/o Synlogic, Inc., 301 Binney Street, Suite 402, Cambridge Ma 02142.
